MyFinsight
Home
Blog
About
Contact
amlx: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$9,261K
Accounts receivable, net
$132K
Marketable securities
$118,812K
Cash and cash
equivalents
$225,178K
Other assets
$2,500K
Operating lease
right-of-use assets
$5,476K
Restricted cash
equivalents
$983K
Property and equipment,
net
$399K
Total current assets
$353,383K
Total assets
$362,741K
Total liabilities and
stockholders' equity
$362,741K
Total stockholders'
equity
$331,996K
Total liabilities
$30,745K
Accumulated deficit
-$718,428K
Accumulated other
comprehensive income (loss)
$815K
Additional paid-in capital
$1,049,598K
Operating lease
liabilities, net of current...
$4,954K
Total current
liabilities
$25,791K
Common stock, 0.0001
par value...
$11K
Operating lease
liabilities, current portion
$981K
Accrued expenses
$19,471K
Accounts payable
$5,339K
Back
Back
Balance Sheet
source: myfinsight.com
Amylyx Pharmaceuticals, Inc. (AMLX)
Amylyx Pharmaceuticals, Inc. (AMLX)